Get alerts of updates about «Development and approval of coronavirus vaccine»
You have subscribed to alerts about:
- Development and approval of coronavirus vaccine
Oops, something went wrong...
... contact nettredaksjon@fhi.no.
... reload the page and try again-
Article
Development and approval of coronavirus vaccine
Published Updated
Several biotechnology companies, global vaccine manufacturers and other organisations are developing vaccines against COVID-19 disease.
Several biotechnology companies, global vaccine manufacturers and other organisations are developing vaccines against COVID-19 disease.
Currently, no vaccine against the new coronavirus has been approved by the European Medicines Agency, and timelines are uncertain. There are a number of publications from the studies for the various vaccine candidates, but much of the supporting data that are necessary for a comprehensive assessment have not yet been published.
The Norwegian Medicines Agency assesses the clinical documentation and approves vaccines for use in Norway, in collaboration with the European Medicines Agency. Several different vaccines are likely to be approved during the pandemic period.
Vaccine technologies
- Read more about the different vaccine technologies used in the development of coronavirus vaccines (Norwegian Medicines Agency)
Approval process
- Read more about the processes for approval of the vaccines (Norwegian Medicines Agency)
